Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma
Objectives and study design: In this population-based study of 602 patients, we amended C-reactive protein (CRP) and plasma albumin (PA) levels around the diagnosis of diffuse large B-cell lymphoma (DLBCL) to the International Prognostic Index (IPI) and assessed 0-90, 91-365, and +365-day survival.R...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2022
|
Texto completo: | http://hdl.handle.net/10362/134567 |
País: | Portugal |
Oai: | oai:run.unl.pt:10362/134567 |